Literature DB >> 6233975

Structural asymmetry of the F1 of Escherichia coli as indicated by reaction with dicyclohexylcarbodiimide.

H R Lötscher, R A Capaldi.   

Abstract

Dicyclohexylcarbodiimide (DCCD) inhibits the ATPase activity of F1 from Escherichia coli by covalent modification of a single glutamic acid in the beta subunit. 95% inhibition was obtained after incorporation of around 1 mole of DCCD per mole F1, i.e. 1 mole of reagent per 3 beta subunits; and up to 2 moles of DCCD per mole F1 were readily incorporated into the protein. One of the 3 beta subunits per F1 can be crosslinked to the epsilon subunit by 1-ethyl-3-[3(dimethylamino)propyl]carbodiimide (EDC). This beta subunit (beta 1) is here shown to be shielded from reaction with DCCD, presumably by its association with epsilon and also possibly the gamma subunit. Thus the three beta subunits are not equivalent in the enzyme complex.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233975     DOI: 10.1016/0006-291x(84)90727-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Chemical modification of active sites in relation to the catalytic mechanism of F1.

Authors:  J H Wang
Journal:  J Bioenerg Biomembr       Date:  1988-08       Impact factor: 2.945

2.  Further studies on the binding of DCCD to cytochrome B and subunit VIII of complex III isolated from beef heart mitochondria.

Authors:  D S Beattie; L Clejan; C G Bosch
Journal:  J Bioenerg Biomembr       Date:  1985-08       Impact factor: 2.945

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.